CONTEXT: -As the number of Zika virus (ZIKV) infections continues to grow, so, too, does the spectrum of recognized clinical disease, in both adult and congenital infections. Defining the tissue pathology associated with the various disease manifestations provides insight into pathogenesis and diagnosis, and potentially future prevention and treatment, of ZIKV infections. OBJECTIVE: -To summarize the syndromes and pathology associated with ZIKV infection, the implications of pathologic findings in the pathogenesis of ZIKV disease, and the use of pathology specimens for diagnosis of ZIKV infection. DATA SOURCES: -The major sources of information for this review were published articles obtained from PubMed and pathologic findings from cases submitted to the Infectious Diseases Pathology Branch at the Centers for Disease Control and Prevention. CONCLUSIONS: -Pathologic findings associated with ZIKV infection are characteristic but not specific. In congenital Zika syndrome, tissue pathology is due to direct viral infection of neural structures, whereas in Guillain-Barré syndrome, pathology is likely due to a postviral, aberrant host-directed immune response. Both fetal and placental pathology specimens are useful for ZIKV diagnosis by molecular and immunohistochemical assays; however, the implications of ZIKV detection in placentas from second- and third-trimester normal live births are unclear, as the potential postnatal effects of late gestational exposure remain to be seen.
CONTEXT: -As the number of Zika virus (ZIKV) infections continues to grow, so, too, does the spectrum of recognized clinical disease, in both adult and congenital infections. Defining the tissue pathology associated with the various disease manifestations provides insight into pathogenesis and diagnosis, and potentially future prevention and treatment, of ZIKV infections. OBJECTIVE: -To summarize the syndromes and pathology associated with ZIKV infection, the implications of pathologic findings in the pathogenesis of ZIKV disease, and the use of pathology specimens for diagnosis of ZIKV infection. DATA SOURCES: -The major sources of information for this review were published articles obtained from PubMed and pathologic findings from cases submitted to the Infectious Diseases Pathology Branch at the Centers for Disease Control and Prevention. CONCLUSIONS: -Pathologic findings associated with ZIKV infection are characteristic but not specific. In congenital Zika syndrome, tissue pathology is due to direct viral infection of neural structures, whereas in Guillain-Barré syndrome, pathology is likely due to a postviral, aberrant host-directed immune response. Both fetal and placental pathology specimens are useful for ZIKV diagnosis by molecular and immunohistochemical assays; however, the implications of ZIKV detection in placentas from second- and third-trimester normal live births are unclear, as the potential postnatal effects of late gestational exposure remain to be seen.
Authors: Avraham Bayer; Nicholas J Lennemann; Yingshi Ouyang; Elena Sadovsky; Megan A Sheridan; R Michael Roberts; Carolyn B Coyne; Yoel Sadovsky Journal: Placenta Date: 2017-11-10 Impact factor: 3.481
Authors: Brett W Jagger; Jonathan J Miner; Bin Cao; Nitin Arora; Amber M Smith; Attila Kovacs; Indira U Mysorekar; Carolyn B Coyne; Michael S Diamond Journal: Cell Host Microbe Date: 2017-09-13 Impact factor: 21.023
Authors: Jacqueline Corry; Nitin Arora; Charles A Good; Yoel Sadovsky; Carolyn B Coyne Journal: Proc Natl Acad Sci U S A Date: 2017-08-07 Impact factor: 11.205
Authors: Christopher J Gregory; Titilope Oduyebo; Aaron C Brault; John T Brooks; Koo-Whang Chung; Susan Hills; Matthew J Kuehnert; Paul Mead; Dana Meaney-Delman; Ingrid Rabe; Erin Staples; Lyle R Petersen Journal: J Infect Dis Date: 2017-12-16 Impact factor: 5.226
Authors: Maria P Fernandez; Edgar Parra Saad; Martha Ospina Martinez; Sheryl Corchuelo; Marcela Mercado Reyes; Maria Jose Herrera; Miguel Parra Saavedra; Angelica Rico; Angela M Fernandez; Richard K Lee; Camila V Ventura; Audina M Berrocal; Sander R Dubovy Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389